If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA set a cut-off date for this month on pharmacies that compound GLP-1 ...

GLP-1 helps our pancreas make more insulin, which can help with blood sugar regulation, and it is involved with appetite regulation. Our own natural GLP-1 is broken down within one to two minutes.

GLP-1 drugs may protect the brain from inflammation, some studies say, but others warn they may increase depression risk. Image credit: James Manning – PA Images/Getty Images.

Compounded GLP-1s helped people continue treatment while brand-name GLP-1 injections were in shortage. But they’re not meant to be a long-term solution when FDA-approved options are available.

While GLP-1 agonists can be a useful tool for weight management, Dr. Balette emphasizes that it’s important to remember that there are multiple factors that can contribute to the development of ...

GLP-1 supplements miss the mark and are not approved by the FDA, Dr. Garcia-Webb says. “Dietary supplements are regulated as food, not drugs, and they cannot claim to treat, diagnose, mitigate ...

Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and possible side effects in compounded meds. Lifestyle habits—like ...

More adults are taking GLP-1 drugs to control their weight, despite recent shortages and high list prices, according to new research. The percentage of overweight or obese adults prescribed a GLP ...

Both Dr. Faris and Dr. Boots also note that it’s important to pair a GLP-1 with a supportive nutrition and exercise plan (whether you’re taking it to mitigate PCOS symptoms or otherwise) so ...

In the realm of innovative health solutions, the HonXi SMGT-GLP-1 Nano Microneedle Patch stands out as a revolutionary approach to managing weight and controlling blood sugar levels. As the prevalence ...

The number of people prescribed GLP-1 drugs for weight management has skyrocketed over the past five years, according to new data from FAIR Health. The report found that just over 2% of adults in ...

GLP-1 drugs are expanding beyond diabetes to potentially reduce heart disease and improve sleep quality. Market for GLP-1 drugs is set to grow from $70 billion in 2025 to $157 billion by 2030, led ...